8-K current report · filed Nov 18, 2026

Medline Inc (MDLN) 8-K Current Report: November 18, 2026

Item 1.01Item 8.01Item EX-99.1MDLN overview

Short answer

Medline Inc (MDLN) filed an 8-K current report with the SEC on November 18, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). $200 million private repurchase of Class A shares and Medline Holdings Common Units from major institutional stockholders.

Medline Inc 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • $200 million private repurchase of Class A shares and Medline Holdings Common Units from major institutional stockholders
  • Repurchase price equal to the Offering underwriting price, aligning transaction economics with the concurrent offering
  • Common Units repurchased trigger equivalent Class B share transfers to Medline for cancellation and retirement
  • Transaction counts toward Medline’s previously announced repurchase program and requires Offering completion
  • Selling stockholders include Blackstone, Carlyle, Hellman & Friedman, GIC, and an Abu Dhabi Investment Authority affiliate

Item 8.01 · Other Events

  • Secondary offering of 60,000,000 Class A shares by selling stockholders
  • Approximately $2.1 billion net proceeds to selling stockholders, not Medline
  • Underwriters’ 30-day option for up to 9,000,000 additional shares
  • Expected November 23, 2026 closing, subject to customary conditions
  • Potential increase in public float and trading liquidity, with no primary capital raise for Medline

Item EX-99.1 · Exhibit EX-99.1

  • Secondary offering priced at $35.50 per share for 60 million shares, with a 9 million-share underwriter option
  • Selling stockholders receive proceeds, not Medline, limiting dilution and providing no new corporate capital
  • Medline and Medline Holdings plan a $200 million equity repurchase from selling stockholders
  • Repurchase expected November 23, 2026, funded at the offering price and counted toward the existing buyback program
  • Potential Class B share cancellation when Common Units are repurchased, simplifying the capital structure

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Medline Inc 8-K filings

Get the next MDLN 8-K as it lands

Follow MDLN for push alerts, or ask the research agent what this filing means.